Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study maps cancer treatment journeys across latin america

NCT ID NCT07192991

Knowledge-focused Sponsor: Latin American Cooperative Oncology Group Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 09, 2026 · Updated 3 times

Summary

This study looks back at medical records of 200 adults in Latin America with a rare and aggressive cancer called neuroendocrine carcinoma. Researchers want to understand how patients are diagnosed, what treatments they receive, and how their disease progresses over time. The goal is to find patterns that can help improve care for future patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with extra-pulmonary neuroendocrine carcinoma (EP-NEC) and patients with pulmonary neuroendocrine carcinoma (SCLC or LCNEC) from Brazil, Mexico, Argentina and Peru.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥18 years old * Diagnosed between August 2014 and August 2024 with one of the following: * Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) * Large-cell neuroendocrine carcinoma (LCNEC) or mixed * Small Cell Lung Cancer (SCLC) or mixed * Adequate and accessible medical records for data collection * Tumor block collected from 2014 onwards Exclusion Criteria: * Patients with active, concurrent malignancies at the time of NEC diagnosis, except for non-invasive cancers like basal cell carcinoma or squamous cell carcinoma of the skin, or in situ cervical cancer. * Patients or their legal representatives unwilling or unable to provide informed consent (if needed per ethics committee).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Large cell neuroendocrine carcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

large cell neuroendocrine carcinoma lung neuroendocrine neoplasm neuroendocrine carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung neuroendocrine carcinoma Neuroendocrine carcinomas

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • A.C. Camargo Cancer Center

    ACTIVE_NOT_RECRUITING

    São Paulo, São Paulo, 01509-001, Brazil

  • ANIMI - Unidade de Tratamento Oncológico

    ACTIVE_NOT_RECRUITING

    Lages, Santa Catarina, 88501-001, Brazil

  • Centro Oncológico Internacional (COI)

    ACTIVE_NOT_RECRUITING

    Mexico City, Mexico City, Mexico

  • Clínica Prognóstica - Centro de Pesquisa Clínica Onconeo

    ACTIVE_NOT_RECRUITING

    Campo Grande, Mato Grosso do Sul, 79002-061, Brazil

  • Futtura Oncologia - Hub de Pesquisa Clínica

    ACTIVE_NOT_RECRUITING

    Porto Alegre, Rio Grande do Sul, 90470-340, Brazil

  • HCL - Hospital do Câncer de Londrina

    ACTIVE_NOT_RECRUITING

    Londrina, Paraná, 86015-520, Brazil

  • HIAE - Hospital Israelita Albert Einstein

    ACTIVE_NOT_RECRUITING

    São Paulo, São Paulo, Brazil

  • HMV - Hospital Moinhos de Vento

    ACTIVE_NOT_RECRUITING

    Porto Alegre, Rio Grande do Sul, 90035-001, Brazil

  • HUOL - Hospital Universitário Onofre Lopes da UFRN

    ACTIVE_NOT_RECRUITING

    Natal, Rio Grande do Norte, 59012-300, Brazil

  • Hospital Británico de Buenos Aires

    RECRUITING

    Buenos Aires, Buenos Aires, Argentina

  • Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO)

    ACTIVE_NOT_RECRUITING

    Cachoeiro de Itapemirim, Espírito Santo, 29308-065, Brazil

  • Hospital de Gastroenterología Carlos Bonorino Udaondo

    RECRUITING

    Buenos Aires, Buenos Aires, Argentina

  • INCA - Instituto Nacional de Câncer

    ACTIVE_NOT_RECRUITING

    Rio de Janeiro, Rio de Janeiro, 20230-130, Brazil

  • INCan - Instituto Nacional de Cancerología

    ACTIVE_NOT_RECRUITING

    Mexico City, Mexico City, Mexico

  • IOP Pesquisa - Instituto de Oncologia do Paraná

    ACTIVE_NOT_RECRUITING

    Curitiba, Paraná, 80040-170, Brazil

  • Instituto Alexander Fleming

    RECRUITING

    Buenos Aires, Buenos Aires, Argentina

  • Liga Norte Riograndense Contra o Câncer

    ACTIVE_NOT_RECRUITING

    Natal, Rio Grande do Norte, 59062-000, Brazil

  • Oncocentro de Minas Gerais (Oncoclínicas)

    ACTIVE_NOT_RECRUITING

    Belo Horizonte, Minas Gerais, 30360-680, Brazil

  • Oncosalud AUNA

    RECRUITING

    Lima, Lima Province, Peru

More trials for these conditions

Other studies related to the condition(s) this trial covers.